Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

• 收藏
• 分享

专利权人:

Transfert Plus; S.E.C.

发明人:

Beliveau, Richard,Annabi, Borhane,Demeule, Michel,Larocque, Alain,Currie, Jean-christophe,Charfi, Cyndia

申请号：

AU2016358324

公开号：

AU2016358324A1

申请日:

2016.11.24

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present disclosure relates to peptide compounds and conjugate compounds, processes, methods and uses thereof for treating cancer and increasing cellular internalization of said peptide compounds. The peptide compounds are selected from the following group consisting of； GVRAKAGVRNMFKSESY as set forth in SEQ ID NO: 9； GVRAKAGVRN(Nle)FKSESY as set forth in SEQ ID NO: 10； and YKSLRRKAPRWDAPLRDPALRQLL as set forth in SEQ ID NO: 11； and wherein at least one protecting group and/or at least one labelling agent is connected to said peptide compound.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/